Ensysce Biosciences, Inc. (ENSC)
NASDAQ: ENSC · Real-Time Price · USD
0.383
+0.000 (0.08%)
At close: Apr 28, 2026, 4:00 PM EDT
0.381
-0.002 (-0.63%)
After-hours: Apr 28, 2026, 7:38 PM EDT
Ensysce Biosciences Market Cap
Ensysce Biosciences has a market cap or net worth of $3.55 million as of April 28, 2026. Its market cap has increased by 22.50% in one year.
Market Cap
3.55M
Enterprise Value
-469.00K
1-Year Change
22.50%
Ranking
Category
Stock Price
$0.38
Market Cap Chart
Since December 1, 2017, Ensysce Biosciences's market cap has decreased from $249.00M to $3.55M, a decrease of -98.57%. That is a compound annual growth rate of -39.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 3.60M | 9.09% |
| Dec 31, 2025 | 3.30M | -68.87% |
| Dec 31, 2024 | 10.60M | 221.21% |
| Dec 29, 2023 | 3.30M | -40.00% |
| Dec 30, 2022 | 5.50M | -95.18% |
| Dec 31, 2021 | 114.00M | 46.34% |
| Dec 31, 2020 | 77.90M | -70.10% |
| Dec 31, 2019 | 260.50M | 6.11% |
| Dec 31, 2018 | 245.50M | -0.89% |
| Dec 29, 2017 | 247.70M | -0.52% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Revelation Biosciences | 4.35M |
| 60 Degrees Pharmaceuticals | 4.30M |
| VivoSim Labs | 4.23M |
| Alzamend Neuro | 4.22M |
| AIM ImmunoTech | 4.21M |
| Galmed Pharmaceuticals | 4.13M |
| Matinas BioPharma Holdings | 3.91M |
| Artelo Biosciences | 3.79M |